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Abstract
Background: EGb761 is a standard extract from the leaves of Ginkgo biloba (Yinxing) containing ginkgo-flavone
glycosides and terpenoid. The flavonoid components of EGb761 scavenge free radicals and protect myocardia from
ischemia-reperfusion injury. The present study aims to determine the effects of the active compounds of EGb761
on mitochondria-dependent caspase pathway.
Methods: Cardiomyocytes were exposed to 24 hours of hypoxia and four hours of reoxygenation, and pretreated
with EGb761, bilobalide and quertcetin. By using immunoblot, immunofluorescent, biochemical and flow cytometry
techniques, we compared the effects of EGb761 and its representative constituents including quercetin and
bilobalides on regulating mitochondria-dependent caspases signal pathway and apoptotic cell death in the
hypoxia-reoxygenated cardiomyocytes.
Results: Pretreatment with EGb761 significantly inhibited the release of cytochrome c from mitochondria, the
expression of caspase-3, cleavage activities of caspases and attenuated apoptotic cell death. The effects of
quercetin on the release of cytochrome c, the cleavage activities of caspases and cell death were similar to those
of EGb761 but better than those of bilobalide.
Conclusion: The antioxidant constituents of EGb761 such as quercetin contribute to the cardioprotective effects of
EGb761 and inhibit the mitochondria-dependent caspase pathway. It is possible that the mitochondria-dependent
caspase pathway may be one of the molecular targets of EGb761 against myocardial ischemia-reperfusion injury.
Background
EGb761 is a standard extract from the leaves of Ginkgo
biloba (Yinxing) containing 24% ginkgo-flavone glyco-
sides (eg kaempferol, quercetin and isorhamnetin deriva-
tives) and 6% terpenoid (eg ginkgolides A, B, C, J and
bilobalide) [1]. The cardioprotective effects of EGb761
have been demonstrated in various in vivo and in vitro
animal models and humans. The flavonoid components
of EGb761 scavenge superoxide, hydroxyl radicals and
nitric oxide (NO) and protect myocardia from ischemia-
reperfusion injury [2-5]. The terpenoid constituents of
EGb761 also showed their cardioprotective effects inde-
pendent from the free radical-scavenging properties [6].
Therefore, it is necessary to further elucidate whether
the cardioprotective mechanisms of EGb761 are attribu-
ted to its flavonoids or terpenoid conponents in the pre-
vention of myocardial ischemia-reperfusion injury.
Mitochondria-dependent caspase-3 pathway is one of
the critical signal pathways in apoptotic cell death dur-
ing myocardial ischemia-reperfusion injury [7]. The
mitochondrial apoptotic pathway plays a pivotal role in
the apoptotic cell death [8]. The release of cytochrome c
from mitochrondria in response to proapoptotic signals
has been suggested as an initiating event in the apopto-
tic process [9]. Cytochrome c released from mitochon-
dria is associated with apoptosis protease activating
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factor (Apaf-1) and pro-caspase-9, triggering the activa-
tion of caspase-3 and resulting in cell death [9]. Reactive
oxygen species (ROS) generated from the ischemia-
reperfused cardiomyocytes trigger apoptotic cell death
[10]. ROS can lead to the release of cytochrome c and
precursors of caspases from the mitochondria into the
cytoplasm [11]. Ischemia-reperfusion initiates the release
of cytochrome c within minutes and the program of
apoptotic cell death within hours in the cardiomyocytes
[12]. Therefore, antioxidant therapy targeting the mito-
chondrial apoptotic pathway may be an important strat-
egy in the treatment of myocardial ischemia-reperfusion
injury. Recent studies show that EGb761can effectively
and extensively counteract the cardial toxicity of doxor-
ubicin via preventing the activation of the p53-mediated,
mitochondrion-dependent apoptotic signaling pathway
[13,14]. EGb761 also protects against mitochondrial dys-
function in platelets and hippocampi in ovariectomized
rats [15]. However, it is unclear yet whether EGb761
can regulate mitochondria-dependent caspases pathway
in ischemia-reperfused cardiomyocytes.
In this study, we selected two representative constitu-
ents of EGb761, namely quercetin and bilobalide, and
compared their effects on the release of cytochrome c
from mitochondria, the expression of caspase 3, the
cleavage activities of caspases and apoptotic cell death.
Methods
Cell culture and drug treatment
Neonatal Wistar rat cardiac myocytes were isolated and
cultured according to the method described in our pre-
vious report [16]. The rats were obtained from the
Laboratory Animal Unit of the University of Hong
Kong. Animal housing, care and application of experi-
mental procedures were all in accordance with the insti-
tutional guidelines and approved by the University
Committee on the Use of Live Animals in Teaching and
Research for the University of Hong Kong. Briefly, after
anesthesia, the hearts from Wistar rats (aged 2-3-days)
were minced and dissociated with 0.06% trypsin (Sigma,
USA). The dispersed cells were incubated on 100 mm
culture dishes for 15 minutes at 37°C with 100% relative
humidity in a CO2 incubator. Non-attached viable cells
were collected and incubated in Dulbecco’s modified
Eagle’s medium (DMEM, Invitrogen, USA) supplemen-
ted with 10% fetal calf serum (FCS), penicillin (50 U/ml)
and streptomycin (50 μg/ml) for six hours, followed by
incubation in the same media supplemented with 10-6
mol/L cytosine arabinoside (Ara C, Sigma, USA) for
48 hours to reduce the rate of non-myocytes. The purity
of the isolated cardiomyocytes was identified to be more
than 90%. The isolated cardiomyocytes were cultured
in high glucose DMEM supplemented with 10% heat-
inactivated FCS, 1% glutamine, 50 U/ml penicillin and
50 μg/ml streptomycin and incubated at 37°C with 100%
relative humidity in a CO2 incubator for three days. To
mimic ischemia, we placed the medium with low glu-
cose DMEM supplemented with 1% FCS, 1% glutamine,
50 U/ml penicillin and 50 μg/ml streptomycin. The car-
diomyocytes were incubated at 37°C in an air-tight incu-
bator from which normal air was removed by a vacuum
pump (GAST DOA-P184-BN, USA) and replaced by 1%
O2/5% CO2 balanced by 95% N2. The cardiomyocytes
were cultured under hypoxia for twenty-four hours. To
mimic reperfusion, we placed the medium with the high
glucose medium supplemented with 10% FCS again and
replaced the gas with 95% air/5% CO2 for four hours.
Corresponding control cells were incubated under the
same conditions but perfused with air (ambient). Prior
to hypoxic treatment, EGb761 (1, 10, 100 μg/ml, IPSEN
Institute, France) and its components quercetin and
bilobalide (1, 10, 100 μg/ml, Sigma, USA) were added
respectively into the media. To confirm whether the
antioxidant therapy reduced the release of cytochrome c
from the cardiomyocytes, prior to hypoxia treatment we
added MnTMPyP (5 μM; A G Scientific, USA), a super-
oxide dismutase (SOD) mimic, to the culture medium
to dismutate cellular superoxide.
Electrophoretic analysis of DNA fragmentation
After hypoxia and reoxygenation treatment, the cells
were washed twice with phosphate buffered saline (PBS),
precipitated by centrifugation and incubated with lysis
buffer [0.2M Tris-HC1, pH8.0; 0.1 M sodium ethylene-
diaminetetracetic (Na2EDTA); 1% SDS and 100 mg/L
proteinase K] for four hours at 55°C. The nuclear lysates
were extracted twice with phenol and then extracted with
an equal volume of phenol-chloroform-isoamyl alcohol
(25:24:1). DNA was precipitated with 5 mol/L sodium
chloride and ethanol overnight at -20°C and spun down
at 6,000 g with Beckman Coulter Avanti-JE Centrifuge
(USA) for 10 minutes at 4°C. The DNA was incubated
with Tris-DETA buffer (10 mM Tris-HC1, pH7.5; 1 mM
Na2EDTA) containing 20 mg/L RNAse A for one hour at
37°C and finally extracted twice with an equal volume of
phenol-chloroform-isoamyl alcohol (25:24:1). After
washed with 75% ethanol, DNA samples were analyzed
with electrophoresis on 1.5% agarose gels with TAE buf-
fer (40 mM Tris-HC1, 20 mM acetic acid and 1 mM
Na2EDTA). The gel was stained with 0.5 μg/ml ethidium
bromide and photographed with UV transillumination.
Detection of DNA fragmentation by ELISA
Cellular DNA fragmentation was determined with the
cell death detection ELISA reagents (Boehringer Man-
nheim, Germany) according to the manufacturer’s
instructions. The DNA fragmentation was expressed
with the enrichment of histone-associated mono- and
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oligonucleosomes released into the cytoplasm. The
enrichment factor (EF) was calculated with absorbance
at 405 nm.
Caspase cleavage assay
Caspase activity was measured as previously described
[17]. Briefly, cells were washed with PBS and suspended
in 500 μl of lysis buffer containing 50 mM Tris-HCl
pH7.4; 1 mM Na2EDTA; 10 mM sodium ethylene glycol
tetraacetic (EGTA) and 10 mM digitonin at 4°C for
30 minutes. Lysates were centrifuged at 7200 g with
Beckman Coulter Centrifuge (USA) for 10 minutes, and
the supernatant containing 50 μg of protein was incu-
bated with 50 μM Ac-DEVD-AMC (Calbiochem, USA)
at 37°C for 30 minutes. The release of 7-amino-4-
methylcoumarin (AMC) was measured in a fluorescence
spectrophotometer (Hitachi F-3010, Japan; excitation
380 nm; emission 460 nm). The enzyme activity was
expressed as fluorescent units per minute per milligram
of protein. The protein concentration of the supernatant
was determined by the Bradford method.
Western blot analysis
Cytochrome c release from mitochondria into the cyto-
sol was measured with Western blot analysis. Cells were
harvested in buffer A containing 20 mM HEPES
(pH7.5), 10 mM KCl, 1.5 mM MgCl2, 1.0 mM
Na2EDTA, 1.0 mM EGTA, 1.0 mM dithiothreitol,
0.1 mM phenylmethylsulfonyl fluoride and 250 mM
sucrose, supplemented with protease inhibitors (10 μg/
ml pepstatin A; 10 μg/ml leupeptin; 10 μg/ml aprotinin).
After sat on ice for 15 minutes, the cells were homoge-
nized and centrifuged at 1,000 g with Beckman Coulter
Avanti-JE Centrifuge (USA) for 15 minutes at 4°C. Then
the supernatants were centrifuged at 10,000 g (Beckman
Coulter Avanti-JE Centrifuge, USA) for 15 minutes at
4°C, and the mitochondrial fractions (pellets) were
resuspended with buffer A. The supernatants prepared
at 10,000 g were further centrifuged at 100,000 g with
Beckman Coulter Optima ™ L-100 XP Ultientrifuge
(USA) for one hour at 4°C. The cytosol fractions (super-
natants) and mitochondrial fractions were stored at
-80°C. Proteins (25 μg) extracted from the cytosol and
mitochondria were separated by 15% SDS-polyacryla-
mide gel electrophoresis and transferred onto nitrocellu-
lose membranes. Membranes were blocked with 5%
nonfat dry milk in Tris-buffered saline containing 0.01%
Tween 20 and incubated with mouse anti-cytochrome c
monoclonal antibody (BD bioscience, USA). b-actin
(1:2000, Sigma, USA) was used as internal control. Blots
were washed, incubated with goat anti-mouse IgG con-
jugated to horseradish peroxidase and developed by
incubation with enhanced chemiluminescence Western
blot detection reagents (Amersham, USA).
For the detection of caspase-3, the cells were lysed
with buffer A. The lysed cells were centrifuged at
12 000 g with Beckman Coulter Avanti-JE Centrifuge
(USA). Equal amounts of protein (40 μg) were used and
Western blot analysis was performed following the same
procedure as the detection of cytochorome c. The
monoclonal antibody against caspase-3 (Calbiochem,
USA) was used. b-actin (1:2000, Sigma, USA) was used
as internal control.
Detection of superoxide production
Cardiomyocytes (2 × 105 cells) were plated on 24-well
plates with a 12 mm glass coverslip precoated with
poly-L-lysine (10 μg/mL). Hydroethidine (HEt, Poly-
science), a reduced derivative of ethidium bromide, can
cross cell membrane and be oxidized by superoxide
(O2
-) specifically, yielding red fluorescent ethidium bro-
mide tightly binding to DNA. The intracellular superox-
ide production was measured from the fluorescence of
HEt. After the hypoxia-reoxygenation experiments, the
cells were incubated with 1 g/ml HEt for 15 minutes in
dark at 37°C and then incubated for one hour in 4%
(wt/vol) paraformaldehyde in PBS for fixation and
washed with PBS. The cover slips were mounted onto
glass slides and these slides were observed with a fluor-
escent microscope (Axioskop 2-plus, Zeiss, USA) at
excitation wavelength between 510 nm and 550 nm and
an emission wavelength at >580 nm.
Statistical analysis
All data were expressed as mean ± standard deviation
(SD). One way ANOVA was used to assess the statistical
significance of differences and followed by Student-New-
man-Keuls (S-N-K) test for two group comparisons. SPSS
16.0 (IBM, USA) was used to perform all stastical analysis.
P < 0.05 was considered as statistically significant.
Results
Effects of EGb761, quercetin and bilobalide on apoptotic
cell death
We first investigated the inhibitory effects of EGb761,
quercetin and bilobalide on apoptotic cell death in the
hypoxia-reoxygenated cardiomyocytes using agarose
electrophoretic analysis and cell death ELISA detection.
As shown in Figure 1, the characteristic ladder pattern
of the DNA fragmentation was found in the hypoxic
cardiomyocytes and the DNA ladder became prodomi-
nant in the hypoxia-reoxygenated cardiomyocytes. Both
EGb761 and quercetin showed inhibitory effects on the
formation of the DNA fragmentation whereas bilobalide
had no effect on the DNA fragmentation. We next
quantitatively determined the apoptotic cell death with a
cell death ELISA kit. The enrichment factor (EF) repre-
sents the enrichment of histone-associated mono- and
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oligo-nucleosomes released into the cytoplasm. The
hypoxia treatment led to produce DNA fragmentation
and the following reoxygenation treatment significantly
increased the magnitude of DNA fragmentation
(hypoxia: EF 1.75 ± 0.17; hypoxia-reoxygenation: EF
2.92 ± 0.21). As shown in Figure 2, EGb761, quercetin
and bilobalide had inhibitory effects on the enrichment
of DNA fragmentations in a dose-dependent manner.
The inhibitory effects of EGb761 and quercetin were
more pronounced than those of bilobalide. These results
indicate that quercetin has better cardioprotective effects
than bilobalide in the cardiomyocytes exposed to
hypoxia-reoxygenation condition.
Effects of EGb761, quercetin and bilobalide on the
release of cytochrome c
We then determined whether EGb761, quercetin and
bilobalide could reduce the release of cytochrome c
from mitochondria, an important apoptotic pathway
triggered by caspases in the hypoxia-reoxygenated cardi-
omyocytes. Figure 3 illustrates the results of immuno-
blot analysis on the expression of cytosol and
mitochondrial cytochrome c. The expression of cyto-
chrome c was predominantly distributed in the mito-
chondrial fractions instead of the cytosol fractions in the
cardiomyocytes under normoxia condition; however,
after the cardiomyocytes were exposed to hypoxia for
24 hours, the expression of cytochrome c in the cytosol
fractions became predominant, indicating that the
hypoxic treatment induces the release of cytochrome c
from the mitochondria. Compared with the hypoxia
group, the cardiomyocytes treated with twenty-four
hours of hypoxia following four hours of reoxygenation
had a significantly enhanced release of cytochrome c
from the mitochondria. Importantly, the treatment of
EGb761 markedly inhibited the release of cytochrome c
from the mitochondria. We also compared the effects of
EGb761 and its ingredients quercetin and bilobalide on
the release of cytochrome c after the hypoxia-reoxygena-
tion treatment. The results showed that EGb761 and
quercetin had much better effects than bilobalide. In
addition, as a positive control, MnTMPyP, a SOD
mimic to dismutate cellular superoxide, was added to
culture medium. Pre-treatment of MnTMPyP also inhib-
ited the release of cytochrome c from the cardiomyo-
cytes after the hypoxia-reoxygenation treatment. These
results suggest that the inhibitory effects of EGb761 on
the release of cytochrome c are mainly attributed to the
antioxidant constitutions or their synergetic actions with
terpenoid components in EGb761.
Effects of EGb761, quercetin and bilobalides on caspases
activities
Next we investigated the cleavage activities of caspases
and the expression of caspase-3 in the hypoxia-
reoxyegenated cardiomyocytes. Ac-DEVD-AMC is a
fluorogenic tetrapeptide substrate cleaved by caspases.
The results showed that the Ac-DEVD-AMC cleaving
activity was significantly elevated in the groups of both
hypoxia treatment and hypoxia-reoxygenation treatment
(control: 0.12 ± 0.04; hypoxia: 0.78 ± 0.06; hypoxia-
reoxygenation: 1.02 ± 0.12 nmol/mg protein/min).
Figure 4 shows the effects of EGb761, quercetin and
bilobalide on the cleavage activities of caspases.
EGb761, quercetin and bilobalides decreased the
Ac-DEVD-AMC cleaving activities in the hypoxia-reoxy-
genated cardiomyocytes in a dose-dependent manner.
Both EGb761 and quercetin had stronger inhibitory
effects on the Ac-DEVD-AMC cleaving activities than
bilobalide. Moreover, the expression of caspase-3 was
detected with Western blot analysis using anti-caspase-3
antibody (Figure 5). The expression of caspase-3 was
Figure 1 Effects of EGb761, quecertin and bilobalide on DNA
fragmentations in the hypoxia-reoxygenated cardiomyocytes.
DNA fragmentation was detected with agarose gel electrophoresis.
(A) hypoxia-reoxygenation (HR); (B) HR + bilobalide (100 μg/ml);
(C) HR + quercetin (100 μg/ml); (D) HR + EGb761 (100 μg/ml);
(E) hypoxia (HO); (F) l DNA/EcoRI+Hind III marker.
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clearly enhanced in both hypoxic and hypoxia-reoxyge-
nated cardiomyocytes. EGb761, quercetin and bilobalide
had dose-dependent inhibitory effects on the expression
of caspase-3 in the hypoxia-reoxygenated cardiomyo-
cytes. Importantly, EGb761 had stronger inhibitory
effects than either quercetin or bilobalide alone, indicat-
ing that the synergetic action of flavonoids and terpe-
noids may contribute to inhibitions of EGb761 on the
activations of caspase pathway in the hypoxia-reoxyge-
nated cardiomyocytes.
Effects of EGb761, quercetin and bilobalides on
scavenging superoxide anions
We finally visualized the production of O2
- in the cardio-
myocytes using HEt-staining fluorescent imaging tech-
nology. As shown in Figure 6, hypoxia-reoxygenation
treatment markedly induced the HEt fluorescence, indi-
cating the production of O2
-. Both EGb761 and quercetin
significantly reduces the production of O2
- in the
hypoxia-reoxygenated cardiomyocytes; however, biloba-
lides had no significant effects on the production of O2
-.
Taken together, these results suggest that the antioxidant
properties of EGb761 contribute to the anti-apoptotic
effects on the hypoxia-reoxygenated cardiomyocytes. The
anti-apoptotic effects of EGb761 are partially attributed
to scavenge superoxide and inhibit the release of
cytochrome c from the mitochondria in the hypoxia-
reoxygenated cardiomyocytes.
Discussion
In the experiments of this study, hypoxia-reoxygenation
induced the production of superoxide, the release of
cytochrome c from mitochrondria, up-regulation of cas-
pase-3, activated the cleavage activities of caspases and
triggered apoptotic cell death in the cardiomyocytes.
EGb761 exhibited cardioprotective effects on scavenging
superoxide, inhibited the release of cytochrome c from
the mitochrondria and the activation of the cleavage
activities of caspases, and prevented apoptotic cell death
in the hypoxia-reoxygenated cardiomyocytes. EGb761
and quercetin had stronger inhibitory effects than the
terpenoid component bilobalide. MnTMPyP, a SOD
mimic to dismutate cellular superoxide, also inhibited
the release of cytochrome c from mitochondria in the
cardiomyocytes after the hypoxia-reoxygenation treat-
ment. Therefore, we hypothesize that the antioxidant
components of EGb761 contribute to the cardioprotec-
tive effects of EGb761 via the regulation of the
mitochondria-dependent caspases pathways. To our
knowledge, the present study provides the first evidence
that EGb761 and its antioxidant components have inhi-
bitory effects on the release of cytochrome c from the
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Figure 2 Effects of EGb761, quecertin and bilobalide on the enrichment factors (EF) of DNA fragmentations in the hypoxia-
reoxygenated cardiomyocytes. DNA fragmentation was determined with the cell death detection ELISA method. EF represented the
enrichment of histone-associated mono- and oligonucleosomes released into the cytoplasm. Drug concentrations of EGb761, quecertin and
bilobalide were 1, 10, 100 μg/ml respectively. Data are shown as mean ± SD (n = 5).
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mitochondria, activation of caspases and apoptotic cell
death in cardiomyocytes under hypoxia-reoxygenation
conditions.
Exposure to hypoxia for 24 hours induced the occur-
rences of DNA fragmentation, a characteristic of apop-
totic cell death. Treatment of hypoxia for 24 hours
followed by four hours of reoxygenation further
increased the magnitude of DNA fragmentation, sug-
gesting reoxygenation exacerbates hypoxia-induced cell
death. In the experiments, hypoxia was accompanied by
the deprivation of glucose and serum whereas reoxy-
genation was co-supplied with glucose and serum,
Figure 3 Effects of EGb761, quecertin and bilobalide on the release of cytochrome c from mitochondria in the hypoxia-reoxygenated
cardiomyocytes. Cytochrome c was detected by Western blot analysis using a monoclonal antibody against cytochrome c. Anti-actin antibody
was used as internal control. (A) effects of MnTMPyP (5 μM) on the release of cytochrome c in hypoxia-reoxygenated cardiomyocytes; (B) effects
of EGb761, quecertin and bilobalide on the release of cytochrome c in hypoxia-reoxygenated cardiomyocytes. HO: Hypoxia; HR: hypoxia-
reoxygenation. Drug concentration of EGb761, quecertin and bilobalide was 100 μg/ml. These representative data were obtained from three
independent experiments.
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similar to the ischemia-reperfusion process. Our results
obtained from the cultured cardiomyocytes are consis-
tent with previous reports using various myocardial
ischemia-reperfusion models [18,19].
Cytochrome c is an essential component of mitochon-
drial respiratory chain and released from the mitochon-
dria in response to various stimuli. Cytosolic
cytochrome c activates caspase-9 cleavages, triggering
the activation of caspase 3 and apoptosis [20]. To clarify
the mitochondrial mechanisms of cell death in the
ischemia-reperfused cardiomyocytes, we investigated the
release of cytochrome c and the cleavage activation of
caspases. The release of cytochrome c into cytosol was
found in the cardiomyocytes exposed to hypoxia for
twenty-four hours and low glucose and low serum; it
became pronounced in the cardiomyocytes after four
hours of reoxygenation. The expression of caspase-3 and
the cleavage activation of caspases were concomitant
with the release of cytochrome c, consistent with pre-
vious studies [21].
Acting as an inhibitor of several reactive oxygen spe-
cies, EGb761 exhibits a wide spectrum of antioxidant
activities [22]. Our previous studies and those of others
suggest that the antioxidant properties of EGb761 con-
tribute to the cardioprotective effects against myocardial
ischemia-reperfusion injury [2,3,23]. In the present
study, EGb761 inhibited the release of cytochrome c
from mitochondria and the cleavage activities of
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Figure 4 Effects of EGb761, quecertin and bilobalide on the expression of caspase-3 in the hypoxia-reoxygenated cardiomyocytes.
Caspase-3 was detected with Western blot analysis using the monoclonal antibody against caspase-3. Anti-actin antibody was used as internal
control. HO: hypoxia; HR: hypoxia-reoxygenation. Drug concentrations of EGb761, quecertin and bilobalide were 1, 10 and 100 μg/ml
respectively. These representative data were obtained from five independent experiments.
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Figure 5 Effects of EGb761, quecertin and bilobalide on the cleavage activities of caspases in the hypoxia-reoxygenated
cardiomyocytes. The extracted proteins from the cardiomyocytes were incubated with Ac-DEVD-AMC and the release of 7-amino-4-
methylcoumarin (AMC) was measured. Drug concentrations of EGb761, quecertin and bilobalide were 1, 10 and 100 μg/ml respectively. HO:
hypoxia; HR: hypoxia-reoxygenation. Data are shown as mean ± SD (n = 5).
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caspases, down-regulated the expression of caspase-3
and prevented apoptotic cell death in the hypoxia-
reoxygenated cardiomyocytes. EGb761 contains both
antioxidant and non-antioxidant ingredients. Our data
clearly showed that quercetin, an antioxant in EGb761,
had stronger inhibitory effects than bilobalide on the
release of cytochrome c, the activation of caspases and
apoptotic cell death in the hypoxia-reoxygenated cardio-
myocytes. Quercetin showed a similar inhibitory effect as
EGb761, suggesting that ginkgo-flavone glycosides may
be the major components of EGb761, contributing to its
cardioprotective effects on inhibiting the release of cyto-
chrome c and activation of caspases. These results are
consistent with the report that flavonoid components
exhibit better effects than Ginkgolides and Bilobalides on
protections of mitochondrial membrane potential in NO-
treated PC12 cells and mouse brain cells [24].
It is necessary to mention that bilobalide also inhibited
the mitochrondria-dependent caspases activation and
prevented the cardiomyocytes from apoptotic cell death
even though the effects of bilobalide were much weaker
than those of quercetin. A previous report suggested
that ginkgolides, the non-flavon fraction of EGb761,
protected PC12 cells against hypoxia-induced injury via
p22/p44 MAPK pathway dependent elevation of HIF-1
transcription efficiency [25]. Therefore, the synergetic
actions of flavone glycosides and terpenoids may contri-
bute to the cardioprotective effects of EGb761 on inhi-
biting the release of cytochrome c and activation of
caspases and preventing cell death during myocardial
ischemia-reperfusion injury.
Conclusion
The antioxidant constituents such as quercetin mainly
contribute to the cardioprotective effects of EGb761 and
inhibit the mitochondria-dependent caspase pathway. It
is possible that the mitochondria-dependent caspase
pathway may be one of the molecular targets of EGb761
against myocardial ischemia-reperfusion injury.
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